This study aims to improve understanding of non-motor symptoms in Parkinson's disease (PD) by testing two new scales: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale. PD is a brain disorder that affects movement and can cause other problems like mood changes. The NFS will help identify how symptoms like mood or concentration change when PD patients are on or off their medication. The SPARK Scale focuses on feelings of shame and embarrassment in PD patients, which can come from symptoms or needing help from others.
Key Points:
- Participants: Minimum of 300 PD patients from Spain, Germany, France, Switzerland, Romania, and Greece.
- Eligibility: Must be 30-75 years old, fluent in the study language, and not have dementia.
- Purpose: To create better tools for doctors to understand and manage PD patient symptoms.
How understandable was the trial content above?
Hard to understand
Easy to understand